ATC codes:
N02BA01
EMLc
Indication
Acute rheumatic fever without mention of heart involvement
ICD11 code:
1B70.Z
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Additional notes
Acute or chronic use for rheumatic fever, juvenile arthritis , Kawasaki disease
Formulations
Local > Rectal > Suppository:
150 mg ;
300 mg
Oral > Solid > dispersible tablet: 75 mg ; 300 mg ; 500 mg
Oral > Solid > tablet: 75 to 500 mg
Oral > Solid > dispersible tablet: 75 mg ; 300 mg ; 500 mg
Oral > Solid > tablet: 75 to 500 mg
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of acetylsalicylic acid:
- the lower strength of the range of strengths for acetylsalicylic acid tablets be changed from 100 mg to 75 mg;
- removal of the 50 mg strength of suppositories, and addition of 300 mg strength of suppositories;
- addition of dispersible tablets (75 g, 300 mg and 500 mg) to facilitate dosing in children unable to swallow solid tablets.